QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序提交时间升序提交时间降序题名升序题名降序作者升序作者降序 Repurposing of the FGFR inhibitor AZD4547 as a potent inhibitor of necroptosis by selectively targeting RIPK1 期刊论文 ACTA PHARMACOLOGICA SINICA, 2022 作者:  Wang, Zuo-wei;  Zou, Feng-ming;  Wang, Ao-li;  Yang, Jing;  Jin, Rui 收藏  |  浏览/下载：17/0  |  提交时间：2022/12/22 AZD4547  RIPK1  inhibitors  SIRS model  anti-necroptosis   RIPK1 inhibitor ameliorates colitis by directly maintaining intestinal barrier homeostasis and regulating following IECs-immuno crosstalk 期刊论文 BIOCHEMICAL PHARMACOLOGY, 2020, 卷号: 172, 页码: 16 作者:  Lu, Huimin;  Li, Heng;  Fan, Chen;  Qi, Qing;  Yan, Yuxi 收藏  |  浏览/下载：43/0  |  提交时间：2020/07/01 RIPK1 inhibitor  Colitis  Barrier homeostasis  IECs-immunocytes crosstalk  Necroptosis  NF-kappa B   Microglia-derived TNF-alpha mediates endothelial necroptosis aggravating blood brain-barrier disruption after ischemic stroke 期刊论文 CELL DEATH & DISEASE, 2019, 卷号: 10, 页码: 18 作者:  Chen, An-Qi;  Fang, Zhi;  Chen, Xiao-Lu;  Yang, Shuai;  Zhou, Yi-Fan 收藏  |  浏览/下载：73/0  |  提交时间：2019/10/14 Identification of the Raf kinase inhibitor TAK-632 and its analogues as potent inhibitors of necroptosis by targeting RIPK1 and RIPK3 期刊论文 BRITISH JOURNAL OF PHARMACOLOGY, 2019, 卷号: 176, 期号: 12 作者:  Qin, Xia;  Hu, Longmiao;  Fu, Jing;  Miao, Zhenyuan;  Li, Zheng-gang 收藏  |  浏览/下载：72/0  |  提交时间：2019/12/05